Target intelligence / Profile preview

Sirtuin enzyme (SIRT (individual family members: SIRT1, SIRT2, ..., SIRT7))

Target
SIRT (individual family members: SIRT1, SIRT2, ..., SIRT7)
Molecular classification
Enzyme, Histone deacetylase (class III), NAD+-dependent deacetylase, Epigenetic modifier
01

Overview

Sirtuin enzymes (SIRTs) are a conserved family of **NAD+-dependent deacetylases** and ADP-ribosyltransferases that regulate the **acetylation state of histones and numerous non-histone substrates**. In mammals, the family includes seven homologs (SIRT1–7) localized to different cellular compartments (nucleus, cytoplasm, mitochondria). Sirtuins modulate fundamental cellular processes, including gene expression, DNA repair, stress response, aging, apoptosis, and metabolism, largely by removing acyl modifications from lysine residues of target proteins. Their activity is tightly coupled to cellular NAD+ levels, linking them to metabolic state. Sirtuins have diverse substrate specificities and play critical roles in cancer, neurodegenerative diseases, metabolic disorders, and aging. Both small molecule inhibitors and activators of sirtuins are under active development for a range of therapeutic indications[2][3][4][5][7][9].

Other names
Sir2-like proteinSirtuin deacetylaseNAD+-dependent deacetylase
02

Mechanism of action

Inhibitors: block the NAD+-dependent deacetylase activity, altering acetylation state of histones and transcription factors Activators: enhance deacetylase activity, promoting deacetylation of specific substrates and downstream gene expression changes

03

Biological functions

Deacetylation of histone and non-histone proteinsRegulation of gene expression (epigenetic regulation)DNA repairRegulation of metabolismModulation of apoptosisControl of cellular senescence and agingRegulation of stress responses
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic diseaseAging and age-related disordersInflammation
05

Safety considerations

Off-target effects due to similarity among SIRT family membersEffects on metabolic and stress response pathways (potential for undesired cell proliferation or apoptosis)Tumorigenicity risk with some modulators (context-dependent)Mitochondrial dysfunction with certain SIRT3 or SIRT5 modulators
06

Interacting drugs

Sirtuin inhibitors (e.g., sirtinol, cambinol, EX-527)

1 more in the full profile.

07

Biomarkers

Acetylation level of histones (e.g., H3, H4) and non-histone proteins (e.g., p53, FOXO3a, PGC-1α)SIRT1/SIRT3 protein or mRNA expressionNAD+/NADH ratio (reflecting sirtuin activity)

Beyond the preview

Go deeper on Sirtuin enzyme (SIRT (individual family members: SIRT1, SIRT2, ..., SIRT7)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirtuin enzyme (SIRT (individual family members: SIRT1, SIRT2, ..., SIRT7)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call